Skip to main content

Day: October 22, 2020

Glacier Bancorp, Inc. Announces Results for the Quarter and Period Ended September 30, 2020

3rd Quarter 2020 Highlights:Net income of $77.8 million for the current quarter, an increase of $26.2 million, or 51 percent, over the prior year third quarter net income of $51.6 million. Current quarter diluted earnings per share of $0.81, an increase of 42 percent from the prior year third quarter diluted earnings per share of $0.57.The loan portfolio organically increased $165 million, or 1 percent, in the current quarter and increased $1.626 billion, or 17 percent, from the prior year third quarter.Core deposits increased $868 million, or 7 percent, during the current quarter, with non-interest bearing deposit growth of $436 million, or 9 percent.  Core deposits organically increased $2.8 billion, or 26 percent, compared to the prior year third quarter, with non-interest bearing deposit growth of $1.6 billion, or 41 percent.Gain...

Continue reading

CapStar Financial Holdings, Inc. Reports Third Quarter 2020 Results

NASHVILLE, Tenn., Oct. 22, 2020 (GLOBE NEWSWIRE) — CapStar Financial Holdings, Inc. (“CapStar”) (NASDAQ:CSTR) today reported third quarter net income of $7.5 million and pre-tax pre-provision income of $11.7 million. Diluted earnings per share were $0.34, a decrease of $0.01 from the third quarter of 2019. Return on average assets and return on average equity for the third quarter of 2020 was 0.98% and 9.26%, respectively.Excluding merger-related charges of $2.5 million, diluted operating(1) earnings per share were $0.43, an increase of $0.07 from the third quarter of 2019. On an operating basis, return on average assets was 1.22% and return on average tangible common equity was 13.76%. Net income and operating earnings for the quarter include a loss on previously terminated interest rate swaps of $1.9 million which will improve...

Continue reading

Theratechnologies to Present at Upcoming Investor Conferences on October 29 and November 10, 2020

MONTREAL, Oct. 22, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that management will be presenting at the following upcoming virtual investor conferences.B. Riley Securities Liver Disease Therapeutics DayThursday, October 29, 2020Panel discussion with Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer29thAnnual Credit Suisse Healthcare ConferenceTuesday, November 10, 2020, 8:45 a.m. ETPresentation by Paul Levesque, President and Chief Executive OfficerTo access the virtual events, please visit the ‘News’ section of the Company’s website. The webcast details will be posted one day before the event date.About TheratechnologiesTheratechnologies (TSX:...

Continue reading

Theratechnologies présentera lors de conférences d’investisseurs le 29 octobre et le 10 novembre 2020

MONTRÉAL, 22 oct. 2020 (GLOBE NEWSWIRE) — Theratechnologies inc. (« Theratechnologies ») (TSX: TH) (NASDAQ: THTX), une société biopharmaceutique commerciale axée sur le développement et la commercialisation de traitements innovateurs, a annoncé aujourd’hui que des membres de la direction présenteront lors des conférences d’investisseurs virtuelles suivantes :B. Riley Securities Liver Disease Therapeutics DayLe jeudi 29 octobre 2020Panel de discussion avec Dr Christian Marsolais, vice-président principal et chef de la direction médicale29th Annual Credit Suisse Healthcare ConferenceLe mardi 10 novembre 2020 à 8h45 (heure de l’Est)Présentation par Paul Lévesque, président et chef de la directionAfin d’accéder aux conférences virtuelles, veuillez consulter nos « Nouvelles » sous la section « Investisseurs » du site web de la Société....

Continue reading

Atlantic Capital Bancshares, Inc. Reports Third Quarter 2020 Results

ATLANTA, Oct. 22, 2020 (GLOBE NEWSWIRE) — Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI) announced net income from continuing operations for the quarter ended September 30, 2020 of $8.6 million, or $0.40 per diluted share, compared to $8.2 million, or $0.33 per diluted share, for the third quarter of 2019 and $1.8 million, or $0.09 per diluted share, for the second quarter of 2020.“We reported another quarter of solid operating results and strong year over year growth in pre-provision, pre-tax net revenue, while continuing to strengthen our fortress balance sheet with the issuance of $75 million in subordinated debt. With confidence in our credit quality, capital strength and earnings outlook, we also resumed our share repurchase program,” remarked Douglas Williams, President and Chief Executive Officer.Third Quarter Highlights(1)Capital...

Continue reading

Altair to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020

TROY, Mich., Oct. 22, 2020 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global technology company providing solutions in data analytics, simulation, and high-performance computing (HPC), will release its financial results for the third quarter 2020, ended September 30, 2020, after the market close on Thursday, November 5, 2020. Management will hold a conference call and webcast on Friday, November 6 at 8:30 a.m. ET to review and discuss the Company’s results for the third quarter. A recorded version of this webcast will be available after the call and accessible at http://investor.altair.com.About AltairAltair is a global technology company that provides software and cloud solutions in the areas of data analytics, simulation, and high-performance computing (HPC). Altair enables organizations across broad industry segments to compete...

Continue reading

South Plains Financial, Inc. Announces Increase to Quarterly Cash Dividend

LUBBOCK, Texas, Oct. 22, 2020 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), the parent company of City Bank, today announced that its Board of Directors has declared a quarterly cash dividend of $0.05 per share of common stock, an increase of $0.02 per share of common stock over the most recent quarterly cash dividend declared in July 2020. The dividend is payable on November 16, 2020 to the Company’s shareholders of record as of the close of business on November 2, 2020. The amount and timing of any future dividend payments to the Company’s shareholders will be subject to the discretion of the Company’s Board of Directors.About South Plains Financial, Inc.South Plains is the bank holding company for City Bank, a Texas state-chartered bank headquartered in Lubbock, Texas. City Bank...

Continue reading

AutoWeb to Hold Third Quarter 2020 Conference Call on Thursday, November 5, 2020 at 5:00 p.m. ET

TAMPA, Fla., Oct. 22, 2020 (GLOBE NEWSWIRE) — AutoWeb, Inc. (Nasdaq: AUTO), a robust digital marketing platform providing advertising solutions for automotive dealers and OEMs, will hold a conference call on Thursday, November 5, 2020 at 5:00 p.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2020. The company will report its financial results in a press release prior to the conference call.AutoWeb President & CEO Jared Rowe and CFO J.P. Hannan will host the conference call, followed by a question-and-answer session.Date: Thursday, November 5, 2020Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)Toll-free dial-in number: 1-877-852-2929International dial-in number: 1-404-991-3925Conference ID: 8329656The conference call will also be broadcast live at www.autoweb.com (click on “Investors”...

Continue reading

Plus Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights

– Received FDA Orphan Drug and Fast Track designations for novel glioblastoma radiotherapy –– Management to host conference call today, Thursday, October 22nd, at 5:00 p.m. ET –AUSTIN, Texas, Oct. 22, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced financial results for the third quarter ended September 30, 2020, and provided an overview of recent business highlights.“Our lead investigational drug, RNL™ for recurrent glioblastoma, continues to progress toward its first major data readout,” said Dr. Marc Hedrick, President and Chief Executive Officer of Plus Therapeutics. “In the third quarter, we advanced RNL successfully to the sixth dosing cohort and we are now administering over 1,000% more radiation to patients in a single treatment than can be delivered with traditional external...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.